Literature DB >> 19508508

Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis.

S Zhang1, F Gao, J Luo, J Yang.   

Abstract

AIM: To determine the factors affecting the survival in colorectal cancer patients with synchronous liver metastases.
METHOD: A total of 168 patients who had been treated colorectal cancer with synchronous liver metastases at Guangxi Medical University from January 2000 to December 2005 were identified. Criteria studied consisted of gender, age, time of symptoms, primary tumour location, primary tumour circumference, histological type, grade (tumour differentiation), T-status, N-status, large bowel obstruction, type of operation, primary tumour resection, ascities, location, number and diameter of liver lesions, preoperative CEA and chemotherapy. Survival curves were plotted using the Kaplan-Meier method. Multivariate analysis was conducted by Cox regression analysis.
RESULTS: The mean survival time for all patients was 18.71 (SEM = 1.59) months. The 1, 2, 3 and 5-year survival rates were 55.95%, 23.21%, 12.30%, 8.0% respectively. Univariate analysis share of grade (tumour differentiation), N-status, large bowel obstruction, operation, primary tumour resection, location, number and the most diameter of liver lesions, extrahepatic transfer, preoperative CEA level and chemotherapy to be predictors of survival. In the Cox regression analysis, the N-status, large bowel obstruction, operation, diameter of liver lesion and extrahepatic transfer were independent factors related to survival.
CONCLUSION: Tumour differentiation, N-status, bowel obstruction, operation, primary tumour resection, location of liver metastasis, number of liver metastasis, diameter of liver metastasis, extrahepatic transfer, preoperative CEA level and chemotherapy are related to the survival of patients with colorectal cancer and synchronous liver metastases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19508508     DOI: 10.1111/j.1463-1318.2009.01911.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  16 in total

1.  An overview of colorectal cancer survival rates and prognosis in Asia.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

2.  Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer.

Authors:  Tetsuro Ikeya; Masatsune Shibutani; Kiyoshi Maeda; Kenji Sugano; Hisashi Nagahara; Hiroshi Ohtani; Kosei Hirakawa
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-15       Impact factor: 4.553

3.  Glutathione S-transferase M1 polymorphism and colorectal cancer risk in Chinese population.

Authors:  Zan Teng; Lei Wang; Jingdong Zhang; Shuang Cai; Yunpeng Liu
Journal:  Tumour Biol       Date:  2013-11-07

Review 4.  Management of colorectal cancer presenting with synchronous liver metastases.

Authors:  Ajith K Siriwardena; James M Mason; Saifee Mullamitha; Helen C Hancock; Santhalingam Jegatheeswaran
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

5.  Intestinal obstruction: predictor of poor prognosis in colorectal carcinoma?

Authors:  Mohd Azri Mohd Suan; Wei Leong Tan; Shahrul Aiman Soelar; Ibtisam Ismail; Muhammad Radzi Abu Hassan
Journal:  Epidemiol Health       Date:  2015-03-30

6.  The Estimation of Survival Function for Colon Cancer Data in Tehran Using Non-parametric Bayesian Model.

Authors:  Alireza Abadi; Farzaneh Ahmadi; Hamid Alavi Majd; Mohammad Esmaeil Akbari; Zainab Abolfazli Khonbi; Esmat Davoudi Monfared
Journal:  Iran J Cancer Prev       Date:  2013

7.  Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

Authors:  Christos Dervenis; Evaghelos Xynos; George Sotiropoulos; Nikolaos Gouvas; Ioannis Boukovinas; Christos Agalianos; Nikolaos Androulakis; Athanasios Athanasiadis; Christos Christodoulou; Evangelia Chrysou; Christos Emmanouilidis; Panagiotis Georgiou; Niki Karachaliou; Ourania Katopodi; Panteleimon Kountourakis; Ioannis Kyriazanos; Thomas Makatsoris; Pavlos Papakostas; Demetris Papamichael; George Pechlivanides; Georgios Pentheroudakis; Ioannis Pilpilidis; Joseph Sgouros; Paris Tekkis; Charina Triantopoulou; Maria Tzardi; Vassilis Vassiliou; Louiza Vini; Spyridon Xynogalos; Nikolaos Ziras; John Souglakos
Journal:  Ann Gastroenterol       Date:  2016-06-03

8.  Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis.

Authors:  Junzhong Lin; Jianhong Peng; Yixin Zhao; Baojia Luo; Yujie Zhao; Yuxiang Deng; Qiaoqi Sui; Yuanhong Gao; Zhifan Zeng; Zhenhai Lu; Zhizhong Pan
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-11       Impact factor: 4.553

9.  First national survival data for colorectal cancer among Saudis between 1994 and 2004: what's next?

Authors:  Mahmoud S Al-Ahwal; Yasmin H Shafik; Hazem M Al-Ahwal
Journal:  BMC Public Health       Date:  2013-01-25       Impact factor: 3.295

10.  Factors related to mortality due to progression of disease in patients with colon cancer in the presence of competing risks: a retrospective cohort study in the west of Iran.

Authors:  Ghodratollah Roshanaei; Malihe Safari; Javad Faradmal; Mohammad Abbasi; Salman Khazaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.